S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

EW Edwards Lifesciences Corp

67.76

1.60 (2.42%)

16 Nov 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Edwards Lifesciences Charts.

Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Edwards Lifesciences Charts.

Edwards Lifesciences Corp News

Shareholders of Edwards Lifesciences Corporation Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EW
Thursday 14 November 2024 (3 days ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 14 November 2024 (4 days ago) • Edgar (US Regulatory)

The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
Monday 11 November 2024 (6 days ago) • PR Newswire (US)

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
Thursday 7 November 2024 (1 week ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

The Gross Law Firm Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
Monday 4 November 2024 (2 weeks ago) • PR Newswire (US)

Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact The Gross Law Firm about pending Class Action - EW
Thursday 31 October 2024 (2 weeks ago) • PR Newswire (US)

Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
Thursday 31 October 2024 (3 weeks ago) • Business Wire

TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
Thursday 31 October 2024 (3 weeks ago) • Business Wire

More Edwards Lifesciences Corp News Articles

Westpac Banking

AUD vs US Dollar

Woodside Petroleum

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions